Allscripts (MDRX) Reports In-Line Q2 EPS; Boosts Bottom-End of FY11 Outlook
Tweet
Share
E-mailGet Alerts MDRX Hot Sheet
Join SI Premium – FREE
Allscripts-Misys Healthcare (NASDAQ: MDRX) reported Q2 EPS of $0.22, in-line with the analyst estimate of $0.22. Revenue for the quarter came in at $363.5 million versus the consensus estimate of $355.76 million.
Allscripts-Misys Healthcare sees FY2011 EPS of $0.88-$0.90, versus prior guidance of $0.86-$0.90 and the consensus of $0.90. Allscripts-Misys Healthcare sees FY2011 revenue of $1440-$1.450 million, versus prior guidance of $1.425-$1.450 million and the consensus of $1.44 million.
Allscripts-Misys Healthcare sees FY2011 EPS of $0.88-$0.90, versus prior guidance of $0.86-$0.90 and the consensus of $0.90. Allscripts-Misys Healthcare sees FY2011 revenue of $1440-$1.450 million, versus prior guidance of $1.425-$1.450 million and the consensus of $1.44 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stride Inc. (LRN) Tops Q3 EPS by 17c, provides guidance
- Seagate forecasts higher Q4 profit on boost from cloud customers
- Eastgroup Properties (EGP) Tops Q1 EPS by 17c, provides guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
